Search Results - "Ye, Xiaocong M."
-
1
Novel cinnoline-based inhibitors of LRRK2 kinase activity
Published in Bioorganic & medicinal chemistry letters (01-01-2013)“…Leucine rich repeat kinase 2 (LRRK2) has been implicated in the pathogenesis of Parkinson’s disease (PD). Inhibition of LRRK2 kinase activity is a therapeutic…”
Get full text
Journal Article -
2
Triazolopyridazine LRRK2 kinase inhibitors
Published in Bioorganic & medicinal chemistry letters (01-04-2013)“…Leucine-rich repeat kinase 2 (LRRK2) has been implicated in the pathogenesis of Parkinson’s disease (PD). Inhibition of LRRK2 kinase activity is a therapeutic…”
Get full text
Journal Article -
3
Discovery of 4-alkylamino-7-aryl-3-cyanoquinoline LRRK2 kinase inhibitors
Published in Bioorganic & medicinal chemistry letters (01-04-2013)“…Mutations in leucine-rich repeat kinase 2 (LRRK2) are associated with familial Parkinson’s disease (PD). The kinase activity of this complex protein is…”
Get full text
Journal Article -
4
Discovery of (R)‑4-Cyclopropyl-7,8-difluoro-5-(4-(trifluoromethyl)phenylsulfonyl)-4,5-dihydro‑1H‑pyrazolo[4,3‑c]quinoline (ELND006) and (R)‑4-Cyclopropyl-8-fluoro-5-(6-(trifluoromethyl)pyridin-3-ylsulfonyl)-4,5-dihydro‑2H‑pyrazolo[4,3‑c]quinoline (ELND007): Metabolically Stable γ‑Secretase Inhibitors that Selectively Inhibit the Production of Amyloid‑β over Notch
Published in Journal of medicinal chemistry (11-07-2013)“…Herein, we describe our strategy to design metabolically stable γ-secretase inhibitors which are selective for inhibition of Aβ generation over Notch. We…”
Get full text
Journal Article -
5
Discovery of a novel [3.2.1] benzo fused bicyclic sulfonamide-pyrazoles as potent, selective and efficacious γ-secretase inhibitors
Published in Bioorganic & medicinal chemistry letters (15-02-2013)“…Structure–activity relationship (SAR) of a novel, potent and metabolically stable series of benzo [3.2.1] bicyclic sulfonamide-pyrazoles as γ-secretase…”
Get full text
Journal Article -
6
Discovery of a novel sulfonamide-pyrazolopiperidine series as potent and Efficacious γ-Secretase Inhibitors
Published in Bioorganic & medicinal chemistry letters (01-04-2010)“…Discovery of a series of pyrazolopiperidine sulfonamide based γ-secretase inhibitors and its SAR evolution is described. Significant increases in APP potency…”
Get full text
Journal Article -
7
Discovery of a novel sulfonamide-pyrazolopiperidine series as potent and efficacious γ-secretase inhibitors (Part II)
Published in Bioorganic & medicinal chemistry letters (15-06-2010)“…Significant improvement in metabolic stability on the pyrazolopiperidine scaffold over the original series were achieved and this stability improvement…”
Get full text
Journal Article -
8
Discovery of ( R )-4-Cyclopropyl-7,8-difluoro-5-(4-(trifluoromethyl)phenylsulfonyl)-4,5-dihydro-1 H -pyrazolo[4,3- c ]quinoline (ELND006) and ( R )-4-Cyclopropyl-8-fluoro-5-(6-(trifluoromethyl)pyridin-3-ylsulfonyl)-4,5-dihydro-2 H -pyrazolo[4,3- c ]quinoline (ELND007): Metabolically Stable γ-Secretase Inhibitors that Selectively Inhibit the Production of Amyloid-β over Notch
Published in Journal of medicinal chemistry (11-07-2013)Get full text
Journal Article -
9
Discovery of a novel [3.2.1] benzo fused bicyclic sulfonamide-pyrazoles as potent, selective and efficacious [gamma]-secretase inhibitors
Published in Bioorganic & medicinal chemistry letters (15-02-2013)“…Structure-activity relationship (SAR) of a novel, potent and metabolically stable series of benzo [3.2.1] bicyclic sulfonamide-pyrazoles as [gamma]-secretase…”
Get full text
Journal Article -
10
Discovery of a novel sulfonamide-pyrazolopiperidine series as potent and Efficacious g-Secretase Inhibitors
Published in Bioorganic & medicinal chemistry letters (01-04-2010)“…Discovery of a series of pyrazolopiperidine sulfonamide based g-secretase inhibitors and its SAR evolution is described. Significant increases in APP potency…”
Get full text
Journal Article